Recruiting NA Primary Nocturnal Enuresis

Tests treatment safety and results for Primary Nocturnal Enuresis

Official title Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov ID: NCT06883851

What this study is testing

What it's testing
The aim of this randomized controlled trial is to evaluate the effects of Structured Pelvic Floor Muscle Rehabilitation (SPFMR) in children with Primary Monosymptomatic Nocturnal Enuresis (PMNE) who are undergoing desmopressin asetat (DDAVP) treatment prescribed by a pediatric urologist. The study aims to investigate whether SPFMR can reduce the frequency and severity of enuresis episodes and whether it can also reduce relapse rates in the short- and long-term follow-up.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 7 to 13

You may be able to join if

  • Being between 7 and 13 years old
  • Diagnosed with primary MNE by a pediatric urology department within the last 6 months
  • No urinary tract infection verified by laboratory tests
  • Ability to communicate in Turkish and absence of mental deficit
  • No diagnosed psychiatric problems

You likely can't join if

  • Presence of orthopedic conditions preventing evaluation
  • Anatomical anomalies in the urinary system
  • History of urinary system surgery
  • Neurological disorders
  • Presence of mental retardation
  • History of orthopedic surgery that could alter pelvic or lower extremity integrity
See the full eligibility criteria
Who can join
  • Being between 7 and 13 years old
  • Diagnosed with primary MNE by a pediatric urology department within the last 6 months
  • No urinary tract infection verified by laboratory tests
  • Ability to communicate in Turkish and absence of mental deficit
  • No diagnosed psychiatric problems
  • Willingness to participate in the study (child and family)
What rules you out
  • Presence of orthopedic conditions preventing evaluation
  • Anatomical anomalies in the urinary system
  • History of urinary system surgery
  • Neurological disorders
  • Presence of mental retardation
  • History of orthopedic surgery that could alter pelvic or lower extremity integrity
  • Receiving PFM rehabilitation in the last 6 months
  • Using nighttime alarm therapy in the last 6 months
  • Receiving any treatment for enuresis in the last 6 months

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Beşiktaş, Turkey (Türkiye)
  • Istanbul, Kadıkoy, Turkey (Türkiye)

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 7 years to 13 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Beşiktaş, Turkey (Türkiye); Istanbul, Kadıkoy, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.